The impact of hepatitis flare on HBeAg loss was effective mainly in the first year of Nucleot(s)ide therapy in chronic hepatitis B
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13449
Abstract: HBeAg loss during nucleos(t)ide analogue (Nuc) therapy is significantly higher in patients with hepatitis flare (ALT ≥ 5‐times upper limited of normal). It is not clear whether ALT level higher above the hepatitis flare leads… read more here.
Keywords: hbeag loss; first year; hepatitis flare; loss ... See more keywords
Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13591
Abstract: Hepatitis B e antigen (HBeAg) is a soluble viral protein in plasma of patients with hepatitis B virus infection. HBeAg loss is an important first stage of viral antigen clearance. We determined the rate and… read more here.
Keywords: hepatitis; cohort; hbeag loss; antigen ... See more keywords
Hepatitis B e antigen and e antibody in a multi‐ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13731
Abstract: Hepatitis B virus e antigen (HBeAg) loss and the appearance of antibodies to HBeAg (anti‐HBe) are favourable events in the history of chronic hepatitis B virus (CHB) infection. Most CHB patients have the HBeAg/anti‐HBe profiles… read more here.
Keywords: hbeag loss; hepatitis virus; hepatitis; hbeag anti ... See more keywords